hers semaglutide out of stock Hims & crashes after FDA announces plans to take "decisive steps" against GLP-1 compounds Hims & Hers Introduces 6-Month
Description
This case underscores the potential for tirzepatide to cause severe gastrointestinal dysmotility and fecal stasis, highlighting the importance of vigilance for bowel complications in patients on GLP-1 RAs who present with acute abdominal symptoms [15]
DAO deficiency is frequently observed in HIT cohorts
Right now, things are gonna get a lot tougher, I would assume over the next year to year and a half, but great products will exceed and overcome all markets, regardless of you know, the strength of them
If your medication IS brand-name and looks colored, do not use it
